INMED PHARMACEUTICALS INC (INM) Institutional Ownership and Insiders Activity

INMED PHARMACEUTICALS INC (INM) is widely held by institutional investors, with 20 firms reporting positions valued at approximately $5.18M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Adar1 Capital Management, Llc is the largest disclosed holder, reporting approximately $1.24M in INM holdings in its latest filing.

Recent insider activity includes 24 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.